Literature DB >> 26484913

Increased Total Homocysteine Levels Predict the Risk of Incident Dementia Independent of Cerebral Small-Vessel Diseases and Vascular Risk Factors.

Kaori Miwa1, Makiko Tanaka2, Shuhei Okazaki1, Yoshiki Yagita3, Manabu Sakaguchi1, Hideki Mochizuki1, Kazuo Kitagawa4.   

Abstract

BACKGROUND: Homocysteine has been identified as a potential risk factor for stroke, cerebral small-vessel diseases (SVD), and dementia.
OBJECTIVE: The present study aimed to investigate the predictive value of homocysteine levels on incident dementia while simultaneously controlling for MRI findings and vascular risk factors.
METHODS: Within a Japanese cohort of participants with vascular risk factors in an observational study, we evaluated the association between baseline total homocysteine (tHcy) levels (per 1 μmol/L and the tertile of tHcy), the prevalence of MRI-findings at baseline, and incident all-cause dementia. Baseline brain MRI was used to determine SVD (lacunas, white matter hyperintensities, and cerebral microbleeds [CMBs]) and atrophy (medial-temporal lobe atrophy and bicaudate ratio). Logistic regression analyses were used to estimate the cross-sectional association between tHcy and each of MRI findings. Cox proportional hazards analyses were performed to estimate the longitudinal association between tHcy and dementia.
RESULTS: In the 643 subjects (age: 67.2 ± 8.4 years, male: 59% ; education: 12.9 ± 2.6 years), multivariable analyses adjusted for several potential confounders, including estimated glomerular filtration rate (eGFR) and intima-media thickness, showed that highest tHcy tertile was associated with lacunas, CMBs, and strictly deep CMBs. During the mean 7.3-year follow-up (range: 2-13), 47 patients were diagnosed with dementia (Alzheimer's disease: 24; vascular dementia: 18; mixed-type: 3; other: 2). After adjusting for age, gender, APOE ɛ4, education, BMI, MMSE, hypertension, cerebrovascular events, eGFR, and MRI-findings, tHcy level (hazard ratios [HR]: 1.08, p = 0.043) and the highest tertile of tHcy (HR: 2.50, p = 0.047) for all-cause dementia remained significant.
CONCLUSIONS: Our results provide additional evidence of tHcy that contributes to increased susceptibility to dementia risk.

Entities:  

Keywords:  Alzheimer’s disease; cerebral small-vessel disease; dementia; estimated glomerular filtration rate; homocysteine; microbleeds; vascular dementia

Mesh:

Substances:

Year:  2016        PMID: 26484913     DOI: 10.3233/JAD-150458

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

1.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis.

Authors:  Stéphanie Debette; Sabrina Schilling; Marie-Gabrielle Duperron; Susanna C Larsson; Hugh S Markus
Journal:  JAMA Neurol       Date:  2019-01-01       Impact factor: 18.302

Review 2.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Authors:  Amy R Nelson; Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Biochim Biophys Acta       Date:  2015-12-17

3.  Application of wavelet analysis to detect dysfunction in cerebral blood flow autoregulation during experimental hyperhomocysteinaemia.

Authors:  Valery V Aleksandrin; Alexander V Ivanov; Edward D Virus; Polina O Bulgakova; Aslan A Kubatiev
Journal:  Lasers Med Sci       Date:  2018-04-03       Impact factor: 3.161

4.  Hydrogen Sulfide Ameliorates Homocysteine-Induced Cognitive Dysfunction by Inhibition of Reactive Aldehydes Involving Upregulation of ALDH2.

Authors:  Min Li; Ping Zhang; Hai-Jun Wei; Man-Hong Li; Wei Zou; Xiang Li; Hong-Feng Gu; Xiao-Qing Tang
Journal:  Int J Neuropsychopharmacol       Date:  2017-04-01       Impact factor: 5.176

5.  Five lipoxygenase hypomethylation mediates the homocysteine effect on Alzheimer's phenotype.

Authors:  Jian-Guo Li; Carlos Barrero; Salim Merali; Domenico Praticò
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

6.  Elevated OPRD1 promoter methylation in Alzheimer's disease patients.

Authors:  Huihui Ji; Yunliang Wang; Guili Liu; Lan Chang; Zhongming Chen; Dongsheng Zhou; Xuting Xu; Wei Cui; Qingxiao Hong; Liting Jiang; Jinfeng Li; Xiaohui Zhou; Ying Li; Zhiping Guo; Qin Zha; Yanfang Niu; Qiuyan Weng; Shiwei Duan; Qinwen Wang
Journal:  PLoS One       Date:  2017-03-02       Impact factor: 3.240

Review 7.  Update on the Neurobiology of Vascular Cognitive Impairment: From Lab to Clinic.

Authors:  Luisa Vinciguerra; Giuseppe Lanza; Valentina Puglisi; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Mariagiovanna Cantone
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

Review 8.  Role of Homocysteine in the Ischemic Stroke and Development of Ischemic Tolerance.

Authors:  Ján Lehotský; Barbara Tothová; Maria Kovalská; Dušan Dobrota; Anna Beňová; Dagmar Kalenská; Peter Kaplán
Journal:  Front Neurosci       Date:  2016-11-23       Impact factor: 4.677

9.  Vitamin B12 Status of Various Ethnic Groups Living in New Zealand: An Analysis of the Adult Nutrition Survey 2008/2009.

Authors:  Asika Devi; Elaine Rush; Michelle Harper; Bernard Venn
Journal:  Nutrients       Date:  2018-02-07       Impact factor: 5.717

10.  Serum homocysteine and risk of dementia in Japan.

Authors:  Sanmei Chen; Takanori Honda; Tomoyuki Ohara; Jun Hata; Yoichiro Hirakawa; Daigo Yoshida; Mao Shibata; Satoko Sakata; Emi Oishi; Yoshihiko Furuta; Takanari Kitazono; Toshiharu Ninomiya
Journal:  J Neurol Neurosurg Psychiatry       Date:  2020-03-31       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.